Infinity Pharmaceuticals (INFI) Earnings
|
Expand Research on INFI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/4/22 | Q222 | N/A | -$0.14 | N/A | N/A | $458.14K | N/A | N/A | N/A | ||
| 5/3/22 |  |
Q122 | -$0.14 | -$0.13 | -$0.01 | $652K | $340K | N/A |  | | Details |
3/29/22  |
|
Q421 | N/A | -$0.13 | N/A | N/A | $300K | N/A | N/A | N/A | |
| 11/2/21 | |
Q321 | -$0.12 | -$0.13 | +$0.01 | N/A | $520K | N/A | | | Details |
| 5/13/21 | |
Q121 | -$0.15 | -$0.12 | -$0.03 | $467K | $1.15M | N/A | | | Details |
| 3/16/21 |
|
Q420 | $0.00 | -$0.16 | +$0.16 | N/A | $280K | N/A | | | Details |
| 11/9/20 |
|
Q320 | N/A | -$0.16 | N/A | N/A | $160K | N/A | N/A | N/A | |
| 7/30/20 | |
Q220 | -$0.16 | -$0.19 | +$0.03 | N/A | $160K | N/A | | | Details |
